Cargando…

Functional differences between protamine preparations for the transfection of mRNA

Protamine is a natural cationic peptide mixture used as a drug for the neutralization of heparin and in formulations of slow-release insulin. In addition, Protamine can be used for the stabilization and delivery of nucleic acids (antisense, small interfering RNA (siRNA), immunostimulatory nucleic ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Jarzebska, Natalia Teresa, Lauchli, Severin, Iselin, Christoph, French, Lars E, Johansen, Pal, Guenova, Emmanuella, Kündig, Thomas M, Pascolo, Steve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470126/
https://www.ncbi.nlm.nih.gov/pubmed/32804028
http://dx.doi.org/10.1080/10717544.2020.1790692
_version_ 1783578524644278272
author Jarzebska, Natalia Teresa
Lauchli, Severin
Iselin, Christoph
French, Lars E
Johansen, Pal
Guenova, Emmanuella
Kündig, Thomas M
Pascolo, Steve
author_facet Jarzebska, Natalia Teresa
Lauchli, Severin
Iselin, Christoph
French, Lars E
Johansen, Pal
Guenova, Emmanuella
Kündig, Thomas M
Pascolo, Steve
author_sort Jarzebska, Natalia Teresa
collection PubMed
description Protamine is a natural cationic peptide mixture used as a drug for the neutralization of heparin and in formulations of slow-release insulin. In addition, Protamine can be used for the stabilization and delivery of nucleic acids (antisense, small interfering RNA (siRNA), immunostimulatory nucleic acids, plasmid DNA, or messenger RNA) and is therefore included in several compositions that are in clinical development. Notably, when mixed with RNA, protamine spontaneously generates particles in the size range of 20–1000 nm depending on the formulation conditions (concentration of the reagents, ratio, and presence of salts). These particles are being used for vaccination and immuno-stimulation. Several grades of protamine are available, and we compared them in the context of complex formation with messenger RNA (mRNA). We found that the different available protamine preparations largely vary in their composition and capacity to transfect mRNA. Our data point to the source of protamine as an important parameter for the production of therapeutic protamine-based complexes.
format Online
Article
Text
id pubmed-7470126
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-74701262020-09-15 Functional differences between protamine preparations for the transfection of mRNA Jarzebska, Natalia Teresa Lauchli, Severin Iselin, Christoph French, Lars E Johansen, Pal Guenova, Emmanuella Kündig, Thomas M Pascolo, Steve Drug Deliv Research Article Protamine is a natural cationic peptide mixture used as a drug for the neutralization of heparin and in formulations of slow-release insulin. In addition, Protamine can be used for the stabilization and delivery of nucleic acids (antisense, small interfering RNA (siRNA), immunostimulatory nucleic acids, plasmid DNA, or messenger RNA) and is therefore included in several compositions that are in clinical development. Notably, when mixed with RNA, protamine spontaneously generates particles in the size range of 20–1000 nm depending on the formulation conditions (concentration of the reagents, ratio, and presence of salts). These particles are being used for vaccination and immuno-stimulation. Several grades of protamine are available, and we compared them in the context of complex formation with messenger RNA (mRNA). We found that the different available protamine preparations largely vary in their composition and capacity to transfect mRNA. Our data point to the source of protamine as an important parameter for the production of therapeutic protamine-based complexes. Taylor & Francis 2020-08-17 /pmc/articles/PMC7470126/ /pubmed/32804028 http://dx.doi.org/10.1080/10717544.2020.1790692 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Jarzebska, Natalia Teresa
Lauchli, Severin
Iselin, Christoph
French, Lars E
Johansen, Pal
Guenova, Emmanuella
Kündig, Thomas M
Pascolo, Steve
Functional differences between protamine preparations for the transfection of mRNA
title Functional differences between protamine preparations for the transfection of mRNA
title_full Functional differences between protamine preparations for the transfection of mRNA
title_fullStr Functional differences between protamine preparations for the transfection of mRNA
title_full_unstemmed Functional differences between protamine preparations for the transfection of mRNA
title_short Functional differences between protamine preparations for the transfection of mRNA
title_sort functional differences between protamine preparations for the transfection of mrna
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470126/
https://www.ncbi.nlm.nih.gov/pubmed/32804028
http://dx.doi.org/10.1080/10717544.2020.1790692
work_keys_str_mv AT jarzebskanataliateresa functionaldifferencesbetweenprotaminepreparationsforthetransfectionofmrna
AT lauchliseverin functionaldifferencesbetweenprotaminepreparationsforthetransfectionofmrna
AT iselinchristoph functionaldifferencesbetweenprotaminepreparationsforthetransfectionofmrna
AT frenchlarse functionaldifferencesbetweenprotaminepreparationsforthetransfectionofmrna
AT johansenpal functionaldifferencesbetweenprotaminepreparationsforthetransfectionofmrna
AT guenovaemmanuella functionaldifferencesbetweenprotaminepreparationsforthetransfectionofmrna
AT kundigthomasm functionaldifferencesbetweenprotaminepreparationsforthetransfectionofmrna
AT pascolosteve functionaldifferencesbetweenprotaminepreparationsforthetransfectionofmrna